Gallant

Ready-to-use stem cell therapies for pets.

San Diego, United States · Founded 2018 · $33.0M raised

Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$33.0M
Last Round
$18.0M Series BJun 2025
Rounds
2

About

Gallant is a San Diego-based animal health biotechnology company redefining veterinary medicine with a pipeline of ready-to-use mesenchymal stem cell therapies derived from uterine tissue. Founded in 2018 by Aaron Hirschhorn, Gallant develops off-the-shelf regenerative therapies targeting inflammatory and degenerative conditions in dogs and cats, including osteoarthritis, feline chronic gingivostomatitis (FCGS), and dermatitis. The company has achieved FDA Technical Section Complete status for Target Animal Safety on its first therapy and operates GallantU, a RACE-approved continuing education platform for veterinary professionals. Gallant's therapies are designed to reduce inflammation, restore function, and fit seamlessly into everyday clinical practice.

Summary

Gallant is a Biotech company based in San Diego, United States, founded in 2018. It has raised $33.0M in total across 2 rounds, most recently a $18.0M Series B round in Jun 2025. Investors include Digitalis Ventures, Bold Capital Partners and Hill Creek Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJun 2025
$18.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Gallant on Indexed.vc
<a href="https://indexed.vc/companies/gallant"><img src="https://indexed.vc/api/badge/company/gallant" alt="Gallant on Indexed.vc" width="260" height="76" /></a>